|
|
Volumn 34, Issue 11, 2016, Pages 1078-
|
|
Railroading at the FDA
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DYSTROPHIN ASSOCIATED PROTEIN;
ETEPLIRSEN;
MORPHOLINO OLIGONUCLEOTIDE;
CLINICAL DECISION MAKING;
DRUG APPROVAL;
DRUG INDUSTRY;
DUCHENNE MUSCULAR DYSTROPHY;
EDITORIAL;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
IMMUNOHISTOCHEMISTRY;
LEADERSHIP;
MUSCULAR DYSTROPHY;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RISK ASSESSMENT;
UNITED STATES;
CLINICAL TRIAL (TOPIC);
DECISION MAKING;
HUMAN;
CLINICAL TRIALS AS TOPIC;
DECISION MAKING;
DRUG APPROVAL;
HUMANS;
MORPHOLINOS;
MUSCULAR DYSTROPHY, DUCHENNE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84994850621
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3733 Document Type: Editorial |
|
Times cited : (13)
|
|
References (0)
|